Sensome is a pioneering start-up founded in 2014 with the slogan "Sensitive Medical Devices." The company is dedicated to the advancement of remote monitoring technology, aiming to transform invasive medical devices into connected healthcare equipment with its groundbreaking innovation. Specializing in the Health Care industry, Sensome is headquartered in France.
The company recently secured a significant investment of €8.00M in a Series B funding round on 12 January 2020. The investors involved in this round include IDInvest Partners, Kurma Partners, Paris Saclay Seed Fund, BNP Paribas Developpement, and Asahi Intecc USA, Inc. This substantial investment is a testament to the potential of Sensome's innovative approach and indicates confidence from prominent investors in the company's vision and capabilities.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | €8.00M | 5 | Paris-Saclay Seed Fund | 12 Jan 2020 |
Seed Round | €4.60M | 2 | 11 Jun 2018 | |
Seed Round | €3.00M | 3 | Paris-Saclay Seed Fund | 10 Jul 2017 |
Seed Round | €1.00M | 1 | 09 Nov 2015 | |
Pre Seed Round | €120.00K | 1 | 19 Feb 2015 |
No recent news or press coverage available for Sensome.